Corticosteroid for severe erythema multiforme
Treatments studied
Part of Skin clinical trials.
This trial tests whether a strong anti-inflammatory medicine (corticosteroid) can help people with severe erythema multiforme, a condition that causes painful skin and mouth sores. It aims to reduce symptoms and speed up recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 15 years old or older and weigh between 66 and 330 pounds.
- You have a severe form of erythema multiforme, which means you have raised, ring-shaped skin sores (target lesions) and/or sores on at least two mucous membranes (like your mouth, eyes, or genitals).
- This is either your first episode of erythema multiforme or a flare-up of a past episode.
- The flare started within the last 5 days.
- You are not pregnant, breastfeeding, or have any other serious health conditions that would make the trial unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new cream (FilmoCream) plus steroid ointment works better than steroid ointment alone for mild-to-moderate eczema. You must have two separate eczema patches that need steroid treatment.
This Phase 3 trial tests how an investigational medicine (PF-06823859) works in adults with active dermatomyositis or polymyositis. It aims to improve disease control by targeting the immune system, but you must meet several safety and diagnosis requirements.
This trial compares two moisturizers for people with eczema (moderate rash) and healthy volunteers. It looks at how well they work and how the skin tolerates them after using a steroid cream.
This trial studies how certain immune cells (eosinophils) behave during severe drug reactions like DRESS and during milder drug rashes. It may help doctors understand what drives organ damage and improve how these reactions are managed.
This trial tests whether a course of steroid medicine can improve outcomes in people with recently started myocarditis (heart muscle inflammation) and mildly reduced heart pumping. It compares steroids versus placebo (inactive treatment) to see if steroids help the heart recover and prevent worsening.
This trial tests an experimental drug called EC-18 (a pill) for people with moderate to severe eczema that hasn't been controlled well with creams. It aims to see if different doses of the drug can safely reduce itching and skin rash.
Hear when a new Erythema Multiforme trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.